Literature DB >> 23819517

Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysis.

Shingo Yamada1, Atsushi Kawaguchi, Takumi Kawaguchi, Nobuyoshi Fukushima, Ryoko Kuromatsu, Shuji Sumie, Akio Takata, Masahito Nakano, Manabu Satani, Tatsuyuki Tonan, Kiminori Fujimoto, Hiroji Shima, Tatsuyuki Kakuma, Takuji Torimura, Michael R Charlton, Michio Sata.   

Abstract

AIM: Various factors are underlying for the onset of non-B, non-C hepatitis virus-related hepatocellular carcinoma (NBNC-HCC). We aimed to investigate the independent risk factors and profiles associated with NBNC-HCC using a data-mining technique.
METHODS: We conducted a case-control study and enrolled 223 NBNC-HCC patients and 669 controls from a health checkup database (n = 176 886). Multivariate analysis, random forest analysis and a decision-tree algorithm were employed to examine the independent risk factors, factors distinguishing between the case and control groups, and to identify profiles for the incidence of NBNC-HCC, respectively.
RESULTS: In multivariate analysis, besides γ-glutamyltransferase (GGT) levels and the Brinkman index, albumin level was an independent negative risk factor for the incidence of NBNC-HCC (odds ratio = 0.67; 95% confidence interval = 0.60-0.70; P < 0.0001). In random forest analysis, serum albumin level was the highest-ranked variable for distinguishing between the case and control groups (98 variable importance). A decision-tree algorithm was created for albumin and GGT levels, the aspartate aminotransferase-to-platelet ratio index (APRI) and the Brinkman index. The serum albumin level was selected as the initial split variable, and 82.5% of the subjects with albumin levels of less than 4.01 g/dL were found to have NBNC-HCC.
CONCLUSION: Data-mining analysis revealed that serum albumin level is an independent risk factor and the most distinguishable factor associated with the incidence of NBNC-HCC. Furthermore, we created an NBNC-HCC profile consisting of albumin and GGT levels, the APRI and the Brinkman index. This profile could be used in the screening strategy for NBNC-HCC.
© 2013 The Japan Society of Hepatology.

Entities:  

Keywords:  lifestyle; metabolism; non-viral-related hepatoma; smoking

Year:  2013        PMID: 23819517     DOI: 10.1111/hepr.12192

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  8 in total

1.  Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012.

Authors:  Keisuke Amano; Takumi Kawaguchi; Ryoko Kuromatsu; Atsushi Kawaguchi; Ichiro Miyajima; Tatsuya Ide; Tatsuyuki Kakuma; Michio Sata
Journal:  Mol Clin Oncol       Date:  2014-08-21

2.  The Relationship of Energy Malnutrition, Skeletal Muscle and Physical Functional Performance in Patients with Stable Chronic Obstructive Pulmonary Disease.

Authors:  Manabu Tomita; Masaru Uchida; Yujiro Imaizumi; Megumi Monji; Emiko Tokushima; Michihiro Kawashima
Journal:  Nutrients       Date:  2022-06-23       Impact factor: 6.706

3.  The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey.

Authors:  Takumi Kawaguchi; Motoyuki Kohjima; Tatsuki Ichikawa; Masataka Seike; Yasushi Ide; Toshihiko Mizuta; Koichi Honda; Kazuhiko Nakao; Makoto Nakamuta; Michio Sata
Journal:  J Gastroenterol       Date:  2014-06-10       Impact factor: 7.527

4.  miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.

Authors:  Yasuo Takashima; Atsushi Kawaguchi; Yasuo Iwadate; Hiroaki Hondoh; Junya Fukai; Koji Kajiwara; Azusa Hayano; Ryuya Yamanaka
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

Review 5.  MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.

Authors:  Takumi Kawaguchi; Tsubasa Tsutsumi; Dan Nakano; Mohammed Eslam; Jacob George; Takuji Torimura
Journal:  Clin Mol Hepatol       Date:  2021-11-10

6.  Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma.

Authors:  Shigeo Shimose; Atsushi Hiraoka; Masatoshi Tanaka; Hideki Iwamoto; Takaaki Tanaka; Kazunori Noguchi; Hajime Aino; Taizo Yamaguchi; Satoshi Itano; Hideya Suga; Takashi Niizeki; Etsuko Moriyama; Tomotake Shirono; Yu Noda; Naoki Kamachi; Shusuke Okamura; Masahito Nakano; Takumi Kawaguchi; Ryoko Kuromatsu; Hironori Koga; Takuji Torimura
Journal:  Sci Rep       Date:  2022-10-11       Impact factor: 4.996

7.  A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD.

Authors:  Takumi Kawaguchi; Katsutoshi Tokushige; Hideyuki Hyogo; Hiroshi Aikata; Tomoaki Nakajima; Masafumi Ono; Miwa Kawanaka; Koji Sawada; Kento Imajo; Koichi Honda; Hirokazu Takahashi; Kohjiroh Mori; Saiyu Tanaka; Yuya Seko; Yuichi Nozaki; Yoshihiro Kamada; Hideki Fujii; Atsushi Kawaguchi; Tetsuo Takehara; Mikio Yanase; Yoshio Sumida; Yuichiro Eguchi; Masataka Seike; Masato Yoneda; Yasuaki Suzuki; Toshiji Saibara; Yoshiyasu Karino; Kazuaki Chayama; Etsuko Hashimoto; Jacob George; Takuji Torimura
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

8.  Therapeutic Outcomes and Prognostic Factors of Unresectable Intrahepatic Cholangiocarcinoma: A Data Mining Analysis.

Authors:  Tomotake Shirono; Takashi Niizeki; Hideki Iwamoto; Shigeo Shimose; Hiroyuki Suzuki; Takumi Kawaguchi; Naoki Kamachi; Yu Noda; Shusuke Okamura; Masahito Nakano; Ryoko Kuromatu; Hironori Koga; Takuji Torimura
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.